Fused heterocyclic derivatives as phosphodiesterase inhibitors

Details Fused heterocyclic derivatives as phosphodiesterase inhibitors Fused heterocyclic derivatives as phosphodiesterase inhibitors

2006-04-25

2006-04-25

Balasubramanian, Venkataraman (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S343000

Reexamination Certificate

active

07034027

ABSTRACT:
Compounds of general structural formula (I) and use of the compounds and salts and solvates thereof, as therapeutic agents.

REFERENCES:
patent: 5859006 (1999-01-01), Daugan
patent: 5981527 (1999-11-01), Daugan et al.
patent: 6046199 (2000-04-01), Pamukcu et al.
patent: 6140329 (2000-10-01), Daugan
patent: 1 022 026 (2000-07-01), None
patent: WO 95/19978 (1995-07-01), None
patent: WO 97/03675 (1997-02-01), None
patent: WO 97/03985 (1997-02-01), None
patent: WO 9703675 (1997-02-01), None
patent: WO 00/66099 (2000-11-01), None
patent: WO 00/66114 (2000-11-01), None
Wang et al., Organic Letters vol. 1 (10) 1647-1649, 1999.
Lucas et al. Pharmacological Reviews 52 (3), 375-413, 2000.
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Loevezijn et al. Tetrahedron Letters 39: 4737-4740, 1998.
E. Sybertz et al.,Exp. Opin. Ther. Patents, 7(6): 631-639 (1997).

Affiliated with

Also associated with

Rating

Fused heterocyclic derivatives as phosphodiesterase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fused heterocyclic derivatives as phosphodiesterase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused heterocyclic derivatives as phosphodiesterase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3561324